Bioceres Crop Solutions reported Q4 2024 revenue of $106.8M, beat analyst consensus of $61.9M by $44.9M. Diluted EPS came in at $0.01, missed the $0.14 consensus by $0.13.
Filings will appear here once submitted to SEC EDGAR.
Common questions about Bioceres Crop Solutions's Q4 2024 earnings report.
Bioceres Crop Solutions (BIOX) reported Q4 2024 earnings on February 11, 2025 before market open.
Bioceres Crop Solutions reported revenue of $106.8M and diluted EPS of $0.01 for Q4 2024.
Revenue beat the consensus estimate of $61.9M by $44.9M. EPS missed the consensus estimate of $0.14 by $0.13.